Table 3

Relative risks of death from disease and overall death within 5 years according to clinicopathological factors and RBM3 expression in all patients (n=343)
Risk of death from disease Risk of death within 5 years
Univariable Multivariable Univariable Multivariable
n (events) HR (95% CI) HR (95% CI) n (events) HR (95% CI) HR (95% CI)
Age
Continuous 299 (100) 1.05 (1.03-1.07) 1.04 (1.02-1.07) 343 (123) 1.07 (1.05-1.08) 1.07 (1.05-1.08)
Gender
Female 72 (28) 1.00 1.00 83 (56) 1.00 1.00
Male 227 (72) 0.79 (0.51-1.23) 1.07 (0.68-1.67) 260 (167) 0.95 (0.70-1.29) 1.24 (0.91-1.70)
Stage
Ta 104 (13) 1.00 1.00 115 (61) 1,00 1.00
T1 97 (25) 2.20 (1.13-4.31) 1.87 (0.85-4.08) 116 (71) 1.37 (0.97-1.94) 1.44 (0.96-2.15)
T2-4 99 (62) 8.86 (4.86-16.16) 6.77 (3.21-14.26) 112 (91) 2.79 (2.01-3.87) 2.90 (1.92-4.40)
Grade
Low 75 (7) 1.00 1.00 82 (41) 1.00 1.00
High 224 (93) 5.75 (2.66-12.40) 1.52 (1.58-3.96) 261 (182) 2.04 (1.45-2.87) 0.90 (0.58-1.39)
RBM3 expression
Positive 232 (66) 1.00 1.00 266 (160) 1.00 1.00
Negative 67 (34) 2.55 (1.68-3.86) 1.65 (1.07-2.53) 77 (63) 2.10 (1.56-2.82) 1.54 (1.13—2.10)

Boman et al.

Boman et al. BMC Urology 2013 13:17   doi:10.1186/1471-2490-13-17

Open Data